4.7 Review

The Specificity of Nitroxyl Chemistry Is Unique Among Nitrogen Oxides in Biological Systems

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 14, 期 9, 页码 1659-1674

出版社

MARY ANN LIEBERT INC
DOI: 10.1089/ars.2010.3841

关键词

-

资金

  1. National Institutes of Health, National Cancer Institute, Center for Cancer Research
  2. NIH [R01-GM076247]
  3. NIH, NIAAA [1F31AA018069-01A1]
  4. National Science Foundation [CHE-0645818]
  5. European Community [PIEF-GA-2008-221666]
  6. Forschungsforderungsfonds [NWF-08/04]

向作者/读者索取更多资源

The importance of nitric oxide in mammalian physiology has been known for nearly 30 years. Similar attention for other nitrogen oxides such as nitroxyl (HNO) has been more recent. While there has been speculation as to the biosynthesis of HNO, its pharmacological benefits have been demonstrated in several pathophysiological settings such as cardiovascular disorders, cancer, and alcoholism. The chemical biology of HNO has been identified as related to, but unique from, that of its redox congener nitric oxide. A summary of these findings as well as a discussion of possible endogenous sources of HNO is presented in this review. Antioxid. Redox Signal. 14, 1659-1674.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Multidisciplinary Sciences

Comment on Evidence that the ProPerDP method is inadequate for protein persulfidation detection due to lack of specificity

Eva Doka, Elias S. J. Arner, Edward E. Schmidt, Tobias P. Dick, Albert van der Vliet, Jing Yang, Reka Szatmari, Tamas Ditroi, John L. Wallace, Giuseppe Cirino, Kenneth Olson, Hozumi Motohashi, Jon M. Fukuto, Michael D. Pluth, Martin Feelisch, Takaaki Akaike, David A. Wink, Louis J. Ignarro, Peter Nagy

Summary: The recent report by Fan et al. alleging the inadequacy of the ProPerDP method for protein persulfidation detection is not supported by their data and is based on methodological shortcomings. Their assumptions and conclusions have not been confirmed by other methods.

SCIENCE ADVANCES (2021)

Review Biochemistry & Molecular Biology

Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment

Christopher L. McGinity, Erika M. Palmieri, Veena Somasundaram, Dibyangana D. Bhattacharyya, Lisa A. Ridnour, Robert Y. S. Cheng, Aideen E. Ryan, Sharon A. Glynn, Douglas D. Thomas, Katrina M. Miranda, Stephen K. Anderson, Stephen J. Lockett, Daniel W. McVicar, David A. Wink

Summary: The metabolic requirements and functions of cancer and normal tissues differ significantly, with distorted vasculature and hypoxia-induced stress commonly observed in tumor microenvironments. Recent studies have shown that alterations in various metabolic pathways dictate tumor behavior and response to therapy, with metabolic heterogeneity within the tumor microenvironment playing a key role in promoting tumor behavior.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemistry & Molecular Biology

HNO Protects the Myocardium against Reperfusion Injury, Inhibiting the mPTP Opening via PKCε Activation

Daniele Mancardi, Pasquale Pagliaro, Lisa A. Ridnour, Carlo G. Tocchetti, Katrina Miranda, Magdalena Juhaszova, Steven J. Sollott, David A. Wink, Nazareno Paolocci

Summary: Nitroxyl (HNO), the one electron-reduction product of nitric oxide (NO), can limit ischemia-reperfusion (I/R) injury by inhibiting the opening of mitochondrial permeability transition pore (mPTP). This study provides insights into the mechanisms of HNO-mediated cardioprotection.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Protein nitration induced by Hemin/NO: A complementary mechanism through the catalytic functions of hemin and NO-scavenging

Amir M. Alsharabasy, Sharon Glynn, Pau Farras, Abhay Pandit

Summary: The study investigated the binding affinity of hemin with (NO)-N-?, the internalization of hemin into MDA-MB-231 cells, and the changes in intracellular nitrated proteins. It also examined the nitration of bovine serum albumin after treatment with hemin and (NO)-N-?, considering factors such as reaction medium pH, H2O2 generation, and tyrosine residue oxidation. The results showed that hemin nitrosylation enhanced cellular uptake, induced protein nitration, and depended on (NO)-N-? concentration and reaction medium pH, with protein scavenging effects playing a crucial role.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2022)

Article Biochemistry & Molecular Biology

Chronic nitric oxide exposure induces prostate cell carcinogenesis, involving genetic instability and a pro-tumorigenic secretory phenotype

Amy J. Burke, Jake D. McAuliffe, Alessandro Natoni, Sarah Ridge, Francis J. Sullivan, Sharon A. Glynn

Summary: NO plays a key role in the development and metastasis of prostate cancer, leading to DNA damage, cell migration, and increased resistance to chemotherapy.

NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2022)

Review Oncology

Targeting Nitric Oxide: Say NO to Metastasis

Tejaswini P. Reddy, Sharon A. Glynn, Timothy R. Billiar, David A. Wink, Jenny C. Chang

Summary: Targeted therapies that reduce cancer metastasis, target chemoresistant cancer stem cells, and enhance the efficacy of systemic chemo/radiotherapies are crucial in reducing cancer-related mortality. Targeting nitric oxide synthase (NOS), a protein in the tumor microenvironment, has shown promise as a therapeutic strategy in various solid malignancies. This review examines the role of nitric oxide (NO) in tumor progression and metastasis, as well as preclinical studies evaluating NOS inhibitors as anticancer therapies. The prospects and challenges of using NOS inhibitors in a clinical setting are also discussed.

CLINICAL CANCER RESEARCH (2023)

Article Biochemistry & Molecular Biology

Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density

Veena Somasundaram, Lisa A. Ridnour, Robert Ys Cheng, Abigail J. Walke, Noemi Kedei, Dibyangana D. Bhattacharyya, Adelaide L. Wink, Elijah F. Edmondson, Donna Butcher, Andrew C. Warner, Tiffany H. Dorsey, David A. Scheiblin, William Heinz, Richard J. Bryant, Robert J. Kinders, Stanley Lipkowitz, Stephen T. C. Wong, Milind Pore, Stephen M. Hewitt, Daniel W. McVicar, Stephen K. Anderson, Jenny Chang, Sharon A. Glynn, Stefan Ambs, Stephen J. Lockett, David A. Wink

Summary: The levels of NOS2/COX2 in tumors influence the polarization and spatial location of lymphoid cells, including CD8(+) T cells. High levels of NOS2/COX2 are associated with the exclusion of CD8(+) T cells from the tumor epithelium. The drug inhibitor indomethacin can improve the penetration ability of CD8(+) T cells and reduce tumor growth, leading to tumor regression.

REDOX BIOLOGY (2022)

Article Cell Biology

Interferon-gamma is quintessential for NOS2 and COX2 expression in ER- breast tumors that lead to poor outcome

Robert Y. S. Cheng, Lisa A. Ridnour, Adelaide L. Wink, Ana L. Gonzalez, Elise L. Femino, Helene Rittscher, Veena Somasundaram, William F. Heinz, Leandro Coutinho, M. Cristina Rangel, Elijah F. Edmondson, Donna Butcher, Robert J. Kinders, Xiaoxian Li, Stephen T. C. Wong, Daniel W. McVicar, Stephen K. Anderson, Milind Pore, Stephen M. Hewitt, Timothy R. Billiar, Sharon A. Glynn, Jenny C. Chang, Stephen J. Lockett, Stefan Ambs, David A. Wink

Summary: A strong correlation between NOS2 and COX2 tumor expression and poor clinical outcomes in ER breast cancer has been established. Analysis of TCGA revealed correlations between NOS2 and COX2 expression and Th1 cytokines. Single-cell RNAseq analysis of TNBC cells showed potent NOS2 and COX2 induction by IFN gamma combined with IL1 beta or TNF alpha.

CELL DEATH & DISEASE (2023)

Article Oncology

ONEST (Observers Needed to Evaluate Subjective Tests) Analysis of Stromal Tumour-Infiltrating Lymphocytes (sTILs) in Breast Cancer and Its Limitations

Balint Cserni, Darren Kilmartin, Mark O'Loughlin, Xavier Andreu, Zsuzsanna Bago-Horvath, Simonetta Bianchi, Ewa Chmielik, Paulo Figueiredo, Giuseppe Floris, Maria Pia Foschini, Aniko Kovacs, Paivi Heikkila, Janina Kulka, Anne-Vibeke Laenkholm, Inta Liepniece-Karele, Caterina Marchio, Elena Provenzano, Peter Regitnig, Angelika Reiner, Ales Ryska, Anna Sapino, Elisabeth Specht Stovgaard, Cecily Quinn, Vasiliki Zolota, Mark Webber, Sharon A. Glynn, Rita Bori, Erika Csorgo, Orsolya Olah-Nemeth, Tamas Pancsa, Anita Sejben, Istvan Sejben, Andras Voros, Tamas Zombori, Tibor Nyari, Grace Callagy, Gabor Cserni

Summary: Tumour-infiltrating lymphocytes (TILs) reflect the host's response against tumours, especially in triple-negative breast cancers. ONEST helps in estimating the number of observers required for a more reliable estimation of inter-observer agreement in TIL assessments, which has not been explored previously. This analysis suggests that between six and nine pathologists can provide a good approximation of inter-observer agreement in TIL assessments.

CANCERS (2023)

Article Biochemistry & Molecular Biology

Chronic Exposure to Nitric Oxide Induces P53 Mutations and Malignant-like Features in Human Breast Epithelial Cells

Robert Y. S. Cheng, Sandra Burkett, Stefan Ambs, Terry Moody, David A. A. Wink, Lisa A. A. Ridnour

Summary: The small signaling molecule nitric oxide (NO) is associated with chronic inflammation and cancer. NO can have both protective and damaging effects on cells depending on its concentration and exposure time. In this study, chronic exposure to NO was found to cause altered phenotypes in breast epithelial cells, including changes in cellular morphology, genomic stability, and RNA and protein expression. These altered phenotypes were associated with malignant characteristics, such as increased expression of cancer stem cell marker CD44 and enhanced motility.

BIOMOLECULES (2023)

Article Chemistry, Medicinal

Nitric Oxide-Scavenging, Anti-Migration Effects, and Glycosylation Changes after Hemin Treatment of Human Triple-Negative Breast Cancer Cells: A Mechanistic Study

Amir M. Alsharabasy, Amal Aljaabary, Raghvendra Bohara, Pau Farras, Sharon A. Glynn, Abhay Pandit

Summary: The study demonstrates that hemin can be used as a potential anticancer agent by scavenging nitric oxide (NO), inhibiting cancer cell migration, and regulating the expression of migration-associated proteins.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2023)

暂无数据